TP53 and urinary bladder carcinoma: Two bladder cancer cell lines (T24 and 253J) with different mutations in the tumor suppressor genes p53 and RB1 and a human fibroblast cell line (VERO) were treated with different concentrations of ligands and complexes (Figure 9).